The rector of the University of Helsinki has appointed Professor Jari Koistinaho as director of the Helsinki Institute of Life Science (HiLIFE).
“The life science disciplines are developing globally in leaps and bounds, thanks to new knowledge and the latest technologies,” notes Koistinaho. “Breakthroughs in life science will change our view of ourselves as humans and our understanding of life, while enabling remarkable applications that can make our lives and environment safer, healthier, more predictable and more diverse. The University of Helsinki’s life science research is internationally excellent, and I see great potential for many significant scientific breakthroughs and applications in the future.”
Koistinaho’s five-year term began on 1 September 2022.
Jari Koistinaho has worked as director of HiLIFE’s Neuroscience Centre since 2018. He is professor of neuropharmacology at the University of Helsinki’s Faculty of Pharmacy, part-time professor of regenerative medicine at the University of Eastern Finland, and docent of neurobiology at Tampere University. He has had a long career at the University of Eastern Finland’s A.I. Virtanen Institute for Molecular Sciences, for example, as dean, as director of Biocenter Kuopio and as professor of stem cell research.
Koistinaho has worked as a researcher and visiting research professor at NIH, UCSF, Stanford School of Medicine and Indiana University School of Medicine in the United States, and at Karolinska Institutet in Stockholm, Sweden. He has established three startups in the pharmaceutical development industry and licensed research-based inventions to international pharmaceutical companies. Jari Koistinaho is a member of the Finnish Academy of Science and Letters.
Photo of Jari Koistinaho: Raija Törrönen, ©UEF/Saastamoinen Foundation